Compile Data Set for Download or QSAR
maximum 50k data
Found 40 Enz. Inhib. hit(s) with all data for entry = 6001
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103938(US8569511, 1)
Affinity DataIC50:  80nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103939(US8569511, 2)
Affinity DataIC50:  94nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103938(US8569511, 1)
Affinity DataIC50:  143nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103939(US8569511, 2)
Affinity DataIC50:  159nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103919(US8569511, 3)
Affinity DataIC50:  229nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103920(US8569511, 4)
Affinity DataIC50:  265nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103924(US8569511, 8)
Affinity DataIC50:  280nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103919(US8569511, 3)
Affinity DataIC50:  283nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103920(US8569511, 4)
Affinity DataIC50:  304nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103926(US8569511, 10)
Affinity DataIC50:  385nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103922(US8569511, 6)
Affinity DataIC50:  410nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103921(US8569511, 5)
Affinity DataIC50:  780nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103928(US8569511, 12)
Affinity DataIC50:  920nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103925(US8569511, 9)
Affinity DataIC50:  1.22E+3nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103923(US8569511, 7)
Affinity DataIC50:  1.23E+3nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103922(US8569511, 6)
Affinity DataIC50:  1.50E+3nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103923(US8569511, 7)
Affinity DataIC50:  1.74E+3nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103924(US8569511, 8)
Affinity DataIC50:  1.94E+3nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103925(US8569511, 9)
Affinity DataIC50:  3.75E+3nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103926(US8569511, 10)
Affinity DataIC50:  4.40E+3nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103932(US8569511, 16)
Affinity DataIC50:  5.17E+3nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103929(US8569511, 13)
Affinity DataIC50:  8.79E+3nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103927(US8569511, 11)
Affinity DataIC50:  1.09E+4nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103928(US8569511, 12)
Affinity DataIC50:  1.16E+4nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103934(US8569511, 18)
Affinity DataIC50:  1.24E+4nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103930(US8569511, 14)
Affinity DataIC50:  1.53E+4nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103929(US8569511, 13)
Affinity DataIC50:  2.11E+4nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103930(US8569511, 14)
Affinity DataIC50:  2.37E+4nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103931(US8569511, 15)
Affinity DataIC50:  3.03E+4nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103935(US8569511, 19)
Affinity DataIC50:  5.39E+4nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103931(US8569511, 15)
Affinity DataIC50:  5.57E+4nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103932(US8569511, 16)
Affinity DataIC50:  5.85E+4nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103936(US8569511, 20)
Affinity DataIC50: >1.00E+5nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103933(US8569511, 17)
Affinity DataIC50: >1.00E+5nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103937(US8569511, 21)
Affinity DataIC50: >1.00E+5nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103937(US8569511, 21)
Affinity DataIC50: >1.00E+5nMAssay Description:The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103935(US8569511, 19)
Affinity DataIC50: >1.00E+5nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103934(US8569511, 18)
Affinity DataIC50: >1.00E+5nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103933(US8569511, 17)
Affinity DataIC50: >1.00E+5nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target3-phosphoinositide-dependent protein kinase 1(Homo sapiens (Human))
University of Utah Research Foundation

US Patent
LigandPNGBDBM103936(US8569511, 20)
Affinity DataIC50: >1.00E+5nMAssay Description:The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.More data for this Ligand-Target Pair
In DepthDetails US Patent